List of Tables
    Table 1. Renal Diseases Drug Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Renal Diseases Drug Market Trends
    Table 3. Renal Diseases Drug Market Drivers
    Table 4. Renal Diseases Drug Market Challenges
    Table 5. Renal Diseases Drug Market Restraints
    Table 6. Global Renal Diseases Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Renal Diseases Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Renal Diseases Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Renal Diseases Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Renal Diseases Drug Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Renal Diseases Drug Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Renal Diseases Drug Revenue Share by Player, 2017-2022
    Table 13. Global Renal Diseases Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Renal Diseases Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Diseases Drug as of 2021)
    Table 15. Top Players of Renal Diseases Drug in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Renal Diseases Drug Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Renal Diseases Drug Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Renal Diseases Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Renal Diseases Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Renal Diseases Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Renal Diseases Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Renal Diseases Drug Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Renal Diseases Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Renal Diseases Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Renal Diseases Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Renal Diseases Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Renal Diseases Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Renal Diseases Drug Product
    Table 33. Pfizer Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Amgen Company Details
    Table 36. Amgen Business Overview
    Table 37. Amgen Renal Diseases Drug Product
    Table 38. Amgen Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 39. Amgen Recent Development
    Table 40. Roche Company Details
    Table 41. Roche Business Overview
    Table 42. Roche Renal Diseases Drug Product
    Table 43. Roche Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 44. Roche Recent Development
    Table 45. GlaxoSmithKline (GSK) Company Details
    Table 46. GlaxoSmithKline (GSK) Business Overview
    Table 47. GlaxoSmithKline (GSK) Renal Diseases Drug Product
    Table 48. GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 49. GlaxoSmithKline (GSK) Recent Development
    Table 50. Allergan Company Details
    Table 51. Allergan Business Overview
    Table 52. Allergan Renal Diseases Drug Product
    Table 53. Allergan Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 54. Allergan Recent Development
    Table 55. AbbVie Company Details
    Table 56. AbbVie Business Overview
    Table 57. AbbVie Renal Diseases Drug Product
    Table 58. AbbVie Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 59. AbbVie Recent Development
    Table 60. Kissei Pharmaceutical Company Details
    Table 61. Kissei Pharmaceutical Business Overview
    Table 62. Kissei Pharmaceutical Renal Diseases Drug Product
    Table 63. Kissei Pharmaceutical Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 64. Kissei Pharmaceutical Recent Development
    Table 65. AstraZeneca Company Details
    Table 66. AstraZeneca Business Overview
    Table 67. AstraZeneca Renal Diseases Drug Product
    Table 68. AstraZeneca Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 69. AstraZeneca Recent Development
    Table 70. FibroGen Company Details
    Table 71. FibroGen Business Overview
    Table 72. FibroGen Renal Diseases Drug Product
    Table 73. FibroGen Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 74. FibroGen Recent Development
    Table 75. Sanofi Company Details
    Table 76. Sanofi Business Overview
    Table 77. Sanofi Renal Diseases Drug Product
    Table 78. Sanofi Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 79. Sanofi Recent Development
    Table 80. Teva Pharmaceutical Industries Company Details
    Table 81. Teva Pharmaceutical Industries Business Overview
    Table 82. Teva Pharmaceutical Industries Renal Diseases Drug Product
    Table 83. Teva Pharmaceutical Industries Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 84. Teva Pharmaceutical Industries Recent Development
    Table 85. Johnson & Johnson Company Details
    Table 86. Johnson & Johnson Business Overview
    Table 87. Johnson & Johnson Renal Diseases Drug Product
    Table 88. Johnson & Johnson Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 89. Johnson & Johnson Recent Development
    Table 90. Keryx Biopharmaceuticals Company Details
    Table 91. Keryx Biopharmaceuticals Business Overview
    Table 92. Keryx Biopharmaceuticals Renal Diseases Drug Product
    Table 93. Keryx Biopharmaceuticals Revenue in Renal Diseases Drug Business (2017-2022) & (US$ Million)
    Table 94. Keryx Biopharmaceuticals Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Renal Diseases Drug Product Picture
    Figure 2. Global Renal Diseases Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Renal Diseases Drug Market Size 2017-2028 (US$ Million)
    Figure 4. United States Renal Diseases Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Renal Diseases Drug Market Size 2017-2028 (US$ Million)
    Figure 6. United States Renal Diseases Drug Market Share in Global 2017-2028
    Figure 7. Renal Diseases Drug Report Years Considered
    Figure 8. Product Picture of Chronic Kidney Disease (CKD) Drugs
    Figure 9. Product Picture of End-Stage Kidney Disease (ESRD) Drugs
    Figure 10. Global Renal Diseases Drug Market Share by Type in 2022 & 2028
    Figure 11. Global Renal Diseases Drug Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Renal Diseases Drug Market Share by Type (2017-2028)
    Figure 13. United States Renal Diseases Drug Market Share by Type in 2022 & 2028
    Figure 14. United States Renal Diseases Drug Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Renal Diseases Drug Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Specialty Clinics
    Figure 18. Product Picture of Other
    Figure 19. Global Renal Diseases Drug Market Share by Application in 2022 & 2028
    Figure 20. Global Renal Diseases Drug Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Renal Diseases Drug Market Share by Application (2017-2028)
    Figure 22. United States Renal Diseases Drug Market Share by Application in 2022 & 2028
    Figure 23. United States Renal Diseases Drug Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Renal Diseases Drug Market Share by Application (2017-2028)
    Figure 25. North America Renal Diseases Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Renal Diseases Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Renal Diseases Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Renal Diseases Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Renal Diseases Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Renal Diseases Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Pfizer Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 54. Amgen Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 55. Roche Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 56. GlaxoSmithKline (GSK) Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 57. Allergan Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 58. AbbVie Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 59. Kissei Pharmaceutical Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 60. AstraZeneca Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 61. FibroGen Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 62. Sanofi Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 63. Teva Pharmaceutical Industries Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 65. Keryx Biopharmaceuticals Revenue Growth Rate in Renal Diseases Drug Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed